Risk of cancer in patients using glucose-lowering agents: a nationwide cohort study of 3.6 million people.
about
Associations between body mass index and development of metabolic disorders in fertile women--a nationwide cohort study.Cancer incidence and mortality in patients with type 2 diabetes treated with human insulin: a cohort study in ShanghaiAssessing the effect of treatment duration on the association between anti-diabetic medication and cancer riskAssociations between metabolic disorders and risk of cancer in Danish men and women--a nationwide cohort study.Effect of Chronic Kidney Diseases on Mortality among Digoxin Users Treated for Non-Valvular Atrial Fibrillation: A Nationwide Register-Based Retrospective Cohort Study.Diabetes and cancer relationships.Impact of metabolic disorders on the relation between overweight/obesity and incident myocardial infarction and ischaemic stroke in fertile women: a nationwide cohort study.Skin cancer in patients with psoriasis.Cardiovascular safety of combination therapies with incretin-based drugs and metformin compared with a combination of metformin and sulphonylurea in type 2 diabetes mellitus--a retrospective nationwide study.Comparison of the clinical outcome of different beta-blockers in heart failure patients: a retrospective nationwide cohort study.Relationship between heart failure, concurrent chronic obstructive pulmonary disease and beta-blocker use: a Danish nationwide cohort study.Association between metformin therapy and incidence, recurrence and mortality of prostate cancer: evidence from a meta-analysis.Associations of type 2 diabetes and diabetes treatment with breast cancer risk and mortality: a population-based cohort study among British womenRelationship Between Gender and the Effectiveness of Montelukast: An Italian/Danish Register-Based Retrospective Cohort StudyComparison of Long-Term Clinical Implications of Beta-Blockade in Patients With Obstructive Airway Diseases Exposed to Beta-Blockers With Different β1-Adrenoreceptor Selectivity: An Italian Population-Based Cohort Study
P2860
Q34297146-2FB22F27-C948-43A1-8786-442CFFDE2AE7Q34545045-504A9FA7-2D8C-4FFE-BBDA-97B3654FC597Q34565654-69EE815E-FA8E-4C14-A162-B2136FA7EC49Q35930159-1B889BB3-1657-462C-B50A-C25A24D25EEFQ36088648-36049182-CD40-4A70-B10F-09AE47053C0CQ38097984-C7F5F2B0-E143-4BED-9979-1048A5C107DBQ38415297-D26C625C-DB5F-45E8-8C4D-D568926C2044Q39955389-96943618-9026-43AD-BDC8-AD1CC02839C5Q43647206-928751CC-06B5-462F-9C5E-25B1036D5F25Q44833507-022CD512-88AD-4DBF-8B04-B46130A646CCQ49841575-EC62FA6B-DBE6-4A8E-BA72-5E8CF5E04E78Q53166209-BC579145-3781-4A96-A31B-D3068A2C3F56Q57910018-43E44AEA-15E3-4407-B3B5-D8E760109DA1Q58803402-DCB79907-08E8-4130-BE1B-A9C5643B02CFQ59136323-F994D9D3-2E77-44D0-9F75-B46FEC849703
P2860
Risk of cancer in patients using glucose-lowering agents: a nationwide cohort study of 3.6 million people.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Risk of cancer in patients usi ...... t study of 3.6 million people.
@ast
Risk of cancer in patients usi ...... t study of 3.6 million people.
@en
type
label
Risk of cancer in patients usi ...... t study of 3.6 million people.
@ast
Risk of cancer in patients usi ...... t study of 3.6 million people.
@en
prefLabel
Risk of cancer in patients usi ...... t study of 3.6 million people.
@ast
Risk of cancer in patients usi ...... t study of 3.6 million people.
@en
P2093
P2860
P50
P1433
P1476
Risk of cancer in patients usi ...... t study of 3.6 million people.
@en
P2093
Allan Vaag
Charlotte Andersson
Christian Selmer
Jesper Lindhardsen
Michelle Schmiegelow
Rikke Sørensen
P2860
P356
10.1136/BMJOPEN-2011-000433
P577
2012-06-08T00:00:00Z